secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2026-06-25T20:46:19+00:00
Accession:  0001628280-26-045569
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharmaceuticals stockholders elect two Class III directors, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- David W.J. McGirr elected with 53.2M votes for, 8.7M withheld; David P. Meeker with 60.0M for, 1.9M withheld.
- Ratification of Ernst & Young as FY2026 auditor approved: 63.9M for, 197.7K against, 23.6K abstained.
- Advisory approval of named executive officer compensation: 50.4M for, 11.5M against, 36.7K abstained.
- Total eligible votes 69.7M; 64.1M votes present (92% of eligible).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000162828026045569/0001628280-26-045569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000162828026045569/rytm-20260624.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-045569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer